Loading...

ICU Medical, Inc. Peer Comparison

Metric Value Ranking
Market Cap $3.9 Billion 5/12 COO
$17.6B
HOLX
$14.2B
ATR
$9.6B
MMSI
$6.3B
ICUI
$3.9B
NVST
$3.7B
XRAY
$3.6B
HAE
$3.1B
ATRC
$2.0B
ATRI
$809.4M
ANGO
$418.4M
AKYA
$114.5M
Gross Margin 35% 11/12 ATRC
75%
COO
67%
AKYA
62%
HOLX
57%
HAE
56%
ANGO
55%
NVST
53%
XRAY
52%
MMSI
46%
ATR
39%
ICUI
35%
ATRI
32%
Profit Margin -6% 8/12 HOLX
20%
COO
12%
ATR
12%
HAE
11%
MMSI
8%
ATRI
1%
NVST
1%
ICUI
-6%
ATRC
-7%
ANGO
-15%
XRAY
-52%
AKYA
-56%
EBITDA margin 1% 9/12 HOLX
34%
ATR
23%
MMSI
22%
COO
19%
HAE
17%
NVST
10%
ATRI
9%
XRAY
7%
ICUI
1%
ATRC
-1%
ANGO
-3%
AKYA
-44%
Quarterly Revenue $589.1 Million 6/12 HOLX
$1.0B
COO
$1.0B
XRAY
$951.0M
ATR
$848.1M
NVST
$601.0M
ICUI
$589.1M
HAE
$348.5M
MMSI
$339.8M
ATRC
$115.9M
ANGO
$72.8M
ATRI
$48.8M
AKYA
$18.8M
Quarterly Earnings -$33.0 Million 11/12 HOLX
$201.0M
COO
$117.5M
ATR
$100.9M
HAE
$37.5M
MMSI
$28.4M
NVST
$8.2M
ATRI
$402,000
ATRC
-$7.9M
AKYA
-$10.5M
ANGO
-$10.7M
ICUI
-$33.0M
XRAY
-$494.0M
Quarterly Free Cash Flow $21.6 Million 7/12 HOLX
$172.5M
ATR
$107.7M
XRAY
$98.0M
NVST
$63.3M
MMSI
$37.4M
HAE
$35.2M
ICUI
$21.6M
ATRC
$16.4M
ATRI
$8.7M
ANGO
$1.7M
COO
-$0
AKYA
-$0
Trailing 4 Quarters Revenue $2.3 Billion 6/12 HOLX
$4.0B
ATR
$3.6B
COO
$3.0B
XRAY
$2.9B
NVST
$2.8B
ICUI
$2.3B
HAE
$1.4B
MMSI
$1.3B
ATRC
$447.6M
ANGO
$286.5M
ATRI
$181.6M
AKYA
$86.8M
Trailing 4 Quarters Earnings -$111.0 Million 9/12 HOLX
$1.0B
COO
$1.0B
XRAY
$951.0M
ATR
$848.1M
NVST
$601.0M
ICUI
$589.1M
HAE
$348.5M
MMSI
$339.8M
ATRC
$115.9M
ANGO
$72.8M
ATRI
$48.8M
AKYA
$18.8M
Quarterly Earnings Growth -556% 12/12 ANGO
63%
ATR
62%
COO
39%
HAE
20%
AKYA
18%
ATRC
13%
MMSI
10%
HOLX
-18%
NVST
-62%
XRAY
-86%
ATRI
-94%
ICUI
-556%
Annual Earnings Growth -392% 10/12 HOLX
44%
MMSI
39%
HAE
23%
AKYA
23%
ATR
19%
COO
15%
ATRI
-26%
ATRC
-59%
ANGO
-307%
ICUI
-392%
NVST
-855%
XRAY
-5900%
Quarterly Revenue Growth 6% 6/12 HOLX
268%
ATRC
18%
ATRI
11%
COO
10%
MMSI
8%
ICUI
6%
HAE
4%
ATR
1%
XRAY
0%
NVST
-5%
ANGO
-8%
AKYA
-25%
Annual Revenue Growth 6% 5/12 HOLX
30%
ATRC
12%
ATRI
11%
NVST
7%
ICUI
6%
HAE
6%
MMSI
4%
ATR
2%
ANGO
-9%
AKYA
-9%
COO
-20%
XRAY
-28%
Cash On Hand $312.5 Million 5/12 HOLX
$1.8B
NVST
$991.3M
MMSI
$523.1M
HAE
$320.8M
ICUI
$312.5M
XRAY
$296.0M
ATR
$223.8M
ATRC
$130.3M
COO
$107.6M
ANGO
$54.1M
AKYA
$12.6M
ATRI
$11.5M
Short Term Debt $51.0 Million 4/12 XRAY
$422.0M
NVST
$115.8M
HOLX
$53.4M
ICUI
$51.0M
COO
$33.3M
MMSI
$11.5M
HAE
$5.1M
AKYA
$3.7M
ATRC
$2.7M
ANGO
-$0
ATR
-$0
ATRI
-$0
Long Term Debt $1.5 Billion 3/12 COO
$2.6B
XRAY
$1.9B
ICUI
$1.5B
NVST
$1.3B
HAE
$1.2B
MMSI
$750.5M
ATR
$688.1M
AKYA
$81.2M
ATRC
$61.9M
HOLX
$22.2M
ANGO
$0
ATRI
$0
PE -1.00 7/12 ATRI
64.46
MMSI
52.50
COO
44.82
ATR
25.71
HAE
24.09
HOLX
19.07
ICUI
-1.00
XRAY
-1.00
ANGO
-1.00
ATRC
-1.00
NVST
-1.00
AKYA
-1.00
PS 1.68 8/12 COO
5.93
MMSI
4.75
ATRC
4.46
ATRI
4.46
HOLX
3.51
ATR
2.69
HAE
2.28
ICUI
1.68
ANGO
1.46
NVST
1.32
AKYA
1.32
XRAY
1.25
PB 1.91 10/12 AKYA
8.40
MMSI
4.76
ATRC
4.29
ATR
3.87
HAE
3.45
ATRI
3.39
HOLX
2.97
ANGO
2.24
COO
2.18
ICUI
1.91
XRAY
1.46
NVST
1.21
PC 12.55 5/12 COO
163.41
ATRI
70.62
ATR
43.01
ATRC
15.31
ICUI
12.55
XRAY
12.30
MMSI
12.05
HAE
9.76
AKYA
9.12
HOLX
7.96
ANGO
7.74
NVST
3.76
Liabilities to Equity 1.10 4/12 AKYA
8.53
HAE
1.79
XRAY
1.66
ICUI
1.10
HOLX
0.83
MMSI
0.80
ATR
0.79
NVST
0.79
ANGO
0.56
COO
0.52
ATRC
0.32
ATRI
0.09
ROA -0.03 7/12 HOLX
9%
ATR
8%
HAE
5%
MMSI
5%
ATRI
5%
COO
3%
ICUI
-3%
ATRC
-6%
XRAY
-7%
NVST
-24%
AKYA
-45%
ANGO
-77%
ROE -0.05 7/12 HOLX
16%
ATR
15%
HAE
14%
MMSI
9%
COO
5%
ATRI
5%
ICUI
-5%
ATRC
-8%
XRAY
-19%
NVST
-44%
ANGO
-120%
AKYA
-425%
Current Ratio 1.91 9/12 ATRI
12.12
ATRC
4.10
COO
2.91
ANGO
2.78
ATR
2.28
NVST
2.26
MMSI
2.25
HOLX
2.21
ICUI
1.91
XRAY
1.60
HAE
1.56
AKYA
1.12
Quick Ratio 0.14 9/12 ATRI
64.46
MMSI
52.50
COO
44.82
ATR
25.71
HAE
24.09
HOLX
19.07
ICUI
-1.00
XRAY
-1.00
ANGO
-1.00
ATRC
-1.00
NVST
-1.00
AKYA
-1.00
Long Term Debt to Equity 0.75 4/12 AKYA}
5.96
HAE}
1.35
XRAY}
0.76
ICUI}
0.75
MMSI}
0.57
NVST}
0.42
COO}
0.32
ATR}
0.28
ATRC}
0.13
HOLX}
0.00
ANGO}
0.00
ATRI}
0.00
Debt to Equity 0.78 4/12 AKYA
6.23
HAE
1.35
XRAY
0.93
ICUI
0.78
MMSI
0.57
NVST
0.46
COO
0.32
ATR
0.28
ATRC
0.13
HOLX
0.01
ANGO
0.00
ATRI
0.00
Burn Rate 2.91 6/12 MMSI
117.73
HAE
25.53
NVST
13.58
ATRC
11.84
ANGO
5.04
ICUI
2.91
AKYA
0.85
XRAY
0.44
ATR
-3.05
HOLX
-9.54
COO
-15.03
ATRI
-28.51
Cash to Cap 0.08 6/12 NVST
0.27
HOLX
0.13
ANGO
0.13
AKYA
0.11
HAE
0.10
ICUI
0.08
XRAY
0.08
MMSI
0.08
ATRC
0.07
ATR
0.02
COO
0.01
ATRI
0.01
CCR -0.65 9/12 ATRI
21.63
NVST
7.72
MMSI
1.32
ATR
1.07
HAE
0.94
HOLX
0.86
ANGO
-0.16
XRAY
-0.20
ICUI
-0.65
ATRC
-2.09
COO
AKYA
EV to EBITDA 631.77 1/12 ICUI}
631.77
ATRI}
175.38
COO}
101.11
MMSI}
88.79
XRAY}
87.16
NVST}
70.63
HAE}
68.39
ATR}
51.78
HOLX}
35.38
AKYA}
-22.38
ANGO}
-145.27
ATRC}
-2059.28
EV to Revenue 2.22 8/12 COO
6.77
MMSI
4.93
ATRI
4.39
ATRC
4.31
HOLX
3.08
HAE
2.94
ATR
2.82
ICUI
2.22
AKYA
2.15
XRAY
1.95
NVST
1.48
ANGO
1.27